Biofourmis inks $35 mln Series B
Singapore and Boston-based Biofourmis, a provider of digital therapeutics, has secured $35 million in Series B financing. Sequoia India, part of Sequoia Capital, led the round.
21 May 2019•1 min read
Singapore and Boston-based Biofourmis, a provider of digital therapeutics, has secured $35 million in Series B financing. Sequoia India, part of Sequoia Capital, led the round.
